(LGHT) Spinnaker Series - Ratings and Ratios

The Spinnaker ETF Series (NYSE ARCA: LGHT) is designed to provide exposure to healthcare technology companies, focusing on U.S. and foreign exchange-listed equity securities, including American Depository Receipts (ADRs). Under normal market conditions, the fund allocates at least 80% of its net assets (plus borrowings for investment purposes) to these securities, which can span any market capitalization. As a non-diversified fund, it may concentrate its holdings in a smaller number of issuers, potentially increasing volatility but also allowing for targeted exposure to the healthcare technology sector, which includes companies involved in telemedicine, health informatics, medical devices, and digital health solutions.

Based on the provided data, the ETF is currently trading below its key moving averages, with the last price of $9.22 sitting below the 20-day SMA of $9.50, 50-day SMA of $10.14, and 200-day SMA of $10.39. The Average True Range (ATR) of 0.19 indicates relatively low price volatility. With an AUM of $3.59M, the fund operates with a smaller asset base, which may impact liquidity and expense ratios. Over the next three months, the ETF is likely to remain under pressure if it continues to trade below its moving averages. The low ATR suggests that price movements will remain subdued, but the small AUM could lead to heightened sensitivity to market shifts. Investors should monitor the funds ability to recover above its 50-day and 200-day SMAs, as this could signal a potential trend reversal.